GLYXAMBI
25MG/5MG TBL FLM 7X1
| SÚKL code | 0219137 |
|---|---|
| Name of the product | GLYXAMBI |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | GLYXAMBI |
| Supplement | 25MG/5MG TBL FLM 7X1 |
| Strenght | 25MG/5MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 7X1 |
| Route | Oral use |
| Wrap type | |
| Legal status | na lékařský předpis |
| Active substance |
LINAGLIPTIN (LINAGLIPTINUM) EMPAGLIFLOZIN (EMPAGLIFLOZINUM) |
| ATC group | A10BD19 |
| ATC group name | LINAGLIPTIN A EMPAGLIFLOZIN |
Marketing authorisation information
| Registration Number | EU/1/16/1146/010 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Boehringer Ingelheim International GmbH, Ingelheim am Rhein |
| MA Holder country | NĚMECKO |
cz